Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · IEX Real-Time Price · USD
2.340
0.00 (0.00%)
At close: May 2, 2024, 4:00 PM
2.290
-0.050 (-2.14%)
After-hours: May 2, 2024, 4:04 PM EDT
Oramed Pharmaceuticals Analyst Ratings
Total Analysts
1
Consensus Rating
Hold
Price Target
$2.00
Upside
-14.53%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Hold Maintains $3 → $2 | Hold | Maintains | $3 → $2 | -14.53% | May 17, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 17, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 12, 2023 |
| Aegis Capital | Aegis Capital | Strong Buy Maintains $35 → $30 | Strong Buy | Maintains | $35 → $30 | +1,182.05% | May 16, 2022 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $20 | Buy | Initiates | $20 | +754.70% | Feb 18, 2022 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Nov 30, 2021 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Nov 29, 2021 |
| Aegis Capital | Aegis Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Nov 2, 2021 |
| Aegis Capital | Aegis Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Jun 8, 2021 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Apr 20, 2021 |
| Aegis Capital | Aegis Capital | Strong Buy Maintains n/a | Strong Buy | Maintains | n/a | n/a | Jan 27, 2021 |
| B. Riley Securities | B. Riley Securities | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Dec 11, 2017 |